taVNS on Pupillary Response and Perceptual Learning

Description

This study has two parts. The study team will evaluate transcutaneous auricular vagal nerve stimulation (taVNS) and two sham settings during a passive task while measuring pupillary response. Second, the study team will assign either taVNS, sham, or no intervention during a go/no-go task and evaluate perceptual learning over three sessions which will also include measuring the pupillary response and electroencephalogram (EEG).

Conditions

Pupillary Response

Study Overview

Study Details

Study overview

This study has two parts. The study team will evaluate transcutaneous auricular vagal nerve stimulation (taVNS) and two sham settings during a passive task while measuring pupillary response. Second, the study team will assign either taVNS, sham, or no intervention during a go/no-go task and evaluate perceptual learning over three sessions which will also include measuring the pupillary response and electroencephalogram (EEG).

The Effect of Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) on Pupillary Response and Perceptual Learning

taVNS on Pupillary Response and Perceptual Learning

Condition
Pupillary Response
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health - Bellevue Hospital, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Healthy individuals 18 to 65
  • * Normal audiometric testing
  • * Co-morbidities including cardiomyopathies, arrhythmias
  • * Implantable devices including vagal stimulators, pacemakers
  • * Presence of metallic implants
  • * Pregnancy

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

NYU Langone Health,

Mario Svirsky, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2028-05